Giving Patients a Chance
Dr. Muaiad Kittaneh give his patients hope. He works as both a researcher and a clinician to bring the latest advances in mesothelioma treatment to his patients.
Over the course of his research, Dr. Muaiad Kittaneh has developed a special interest in cancer genomics. He’s particularly passionate about studying the BAP1 gene mutation, which allows for unchecked tumor growth.
Advances in Research
Over the course of his research, Dr. Kittaneh has developed a special interest in cancer genomics. He’s particularly passionate about studying the BAP1 gene mutation, which allows for unchecked tumor growth. Dr. Kittaneh remains optimistic about treating mesothelioma, noting that survival rates for this disease are on the rise.
A Multidisciplinary Approach
Dr. Kittaneh practices a multidisciplinary approach to care. He works with a tumor board consisting of pathologists, medical oncologists, radiation oncologists, and surgical oncologists to develop his patients’ treatment plans and provide them with the best care.